SECCR continues to carry out research ethics. The committee actively undertakes national and Shanghai ethics-related topics and independently conducts academic research. At the same time, we introduce foreign advanced ethical standards and concepts, formulate relevant ethics standards lacking in China, and provide consultation for the government's strategic decision-making in the field of biomedicine and health.

In recent years, SECCR has led 3 scientific research projects of Shanghai Science and Technology Commission and Shanghai Municipal Health Commission, participated in the establishment of 1 major project of Shanghai Science and Technology, led the formulation of ethics review guidelines for cosmetics and biobanks, published 5 papers, and published the 2016 edition of CIOMS International Ethical Guidelines for Health-related Research Involving Humans, etc. Some of the research work carried out is as follows:

• Shanghai Science and Technology Commission Project: “The Biological Medicine Clinical Research Ethics Review the Research of the System Construction and the Mechanism of Mutual Recognition"
• Shanghai Municipal Health Commission Project: “The Study of Cell Therapy Clinical Research Ethics Review and Supervision”, “The Yangtze River Delta Research on the Mechanism of Coordination and Mutual Recognition of Ethics Review”
• SECCR has officially published the 2016 edition CIOMS International Ethical Guidelines for Health-related Research Involving Humans in Chinese. The standard Chinese version is translated by SECCR, funded and published by Shanghai Clinical Research Center, 2019
• Published “Best Practices for Human Biobank Ethics Review in China” (Chinese & English versions), 2020
• Participated in formulating “Ethical Principles for Life Science and Medical Research Involving Human Subjects” (Draft), 2021
• Lead in formulating “Guidelines for Ethical Review of Human Testing of Cosmetics”, 2021-2022
• Lead in formulating “Ethical Review of Research Using Human Biological Samples and Health-Related Data”, Technical Guide Document, 2022
• Participated in compiling Stem Cell Research in China: From Basic to Clinical